
Roy R. Teller
Examiner (ID: 12058, Phone: (571)272-0971 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675, 1653 |
| Total Applications | 671 |
| Issued Applications | 374 |
| Pending Applications | 45 |
| Abandoned Applications | 251 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8571726
[patent_doc_number] => 08338371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/094931
[patent_app_country] => US
[patent_app_date] => 2006-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1602
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12094931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094931 | Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof | Nov 23, 2006 | Issued |
Array
(
[id] => 23818
[patent_doc_number] => 07795207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Lipopeptide compositions'
[patent_app_type] => utility
[patent_app_number] => 11/604010
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10603
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604010 | Lipopeptide compositions | Nov 20, 2006 | Issued |
Array
(
[id] => 267170
[patent_doc_number] => 07566696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => 'Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/583267
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10146
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566696.pdf
[firstpage_image] =>[orig_patent_app_number] => 11583267
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/583267 | Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis | Oct 18, 2006 | Issued |
Array
(
[id] => 4675561
[patent_doc_number] => 20080213190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Selective Alfavbetas Receptor Peptide Antagonist for Therapeutic and Diagnostic Applications'
[patent_app_type] => utility
[patent_app_number] => 12/089709
[patent_app_country] => US
[patent_app_date] => 2006-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4632
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213190.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089709 | Selective αvβ3 receptor peptide antagonist for therapeutic and diagnostic applications | Oct 8, 2006 | Issued |
Array
(
[id] => 5205601
[patent_doc_number] => 20070027083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Human growth hormone aqueous formulation'
[patent_app_type] => utility
[patent_app_number] => 11/529677
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3430
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027083.pdf
[firstpage_image] =>[orig_patent_app_number] => 11529677
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/529677 | Human growth hormone aqueous formulation | Sep 27, 2006 | Abandoned |
Array
(
[id] => 8469852
[patent_doc_number] => 08299029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Stabilised solid compositions of factor VII polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/526503
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 15455
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11526503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526503 | Stabilised solid compositions of factor VII polypeptides | Sep 24, 2006 | Issued |
Array
(
[id] => 5136465
[patent_doc_number] => 20070078094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Guanidinium delivery carriers'
[patent_app_type] => utility
[patent_app_number] => 11/526224
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16032
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078094.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526224 | Guanidinium delivery carriers | Sep 21, 2006 | Issued |
Array
(
[id] => 795650
[patent_doc_number] => 07429566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Method for treating Hemophilia B'
[patent_app_type] => utility
[patent_app_number] => 11/521902
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1866
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429566.pdf
[firstpage_image] =>[orig_patent_app_number] => 11521902
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/521902 | Method for treating Hemophilia B | Sep 14, 2006 | Issued |
Array
(
[id] => 5361574
[patent_doc_number] => 20090036368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Therapeutic Combination'
[patent_app_type] => utility
[patent_app_number] => 11/991926
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8439
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036368.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991926
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991926 | Therapeutic Combination | Sep 13, 2006 | Abandoned |
Array
(
[id] => 4652127
[patent_doc_number] => 20080039383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Methods and compositions for inhibiting ER-stress induced cholesterol/triglyceride accumulation'
[patent_app_type] => utility
[patent_app_number] => 11/498968
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26983
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039383.pdf
[firstpage_image] =>[orig_patent_app_number] => 11498968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/498968 | Methods and compositions for inhibiting ER-stress induced cholesterol/triglyceride accumulation | Aug 1, 2006 | Abandoned |
Array
(
[id] => 5575924
[patent_doc_number] => 20090143286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Methods and Compositions for Regenerating Articular Cartilage'
[patent_app_type] => utility
[patent_app_number] => 11/989802
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5948
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143286.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989802
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989802 | Methods and compositions for regenerating articular cartilage | Jul 31, 2006 | Issued |
Array
(
[id] => 5732726
[patent_doc_number] => 20060257843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Kappa-PVIIA-related conotoxins as organ protectants'
[patent_app_type] => utility
[patent_app_number] => 11/490133
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15538
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490133 | Kappa-PVIIA-related conotoxins as organ protectants | Jul 20, 2006 | Abandoned |
Array
(
[id] => 4927887
[patent_doc_number] => 20080167250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Method For Induction and Enhancement of Apoptosis In Tumor Cells'
[patent_app_type] => utility
[patent_app_number] => 11/994759
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8352
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994759
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994759 | Method for induction and enhancement of apoptosis in tumor cells | Jul 19, 2006 | Issued |
Array
(
[id] => 5662094
[patent_doc_number] => 20060252690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Factor VII or VIIa - Like Molecules'
[patent_app_type] => utility
[patent_app_number] => 11/426401
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29159
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252690.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426401 | Factor VII or VIIa-like molecules | Jun 25, 2006 | Issued |
Array
(
[id] => 5662093
[patent_doc_number] => 20060252689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Factor VII or VIIa - Like Molecules'
[patent_app_type] => utility
[patent_app_number] => 11/426394
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29157
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11426394
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/426394 | Factor VII or VIIa - Like Molecules | Jun 25, 2006 | Abandoned |
Array
(
[id] => 5700069
[patent_doc_number] => 20060216753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Binding Proteins as Biosensors'
[patent_app_type] => utility
[patent_app_number] => 11/424894
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7183
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216753.pdf
[firstpage_image] =>[orig_patent_app_number] => 11424894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/424894 | Binding proteins as biosensors | Jun 18, 2006 | Issued |
Array
(
[id] => 925611
[patent_doc_number] => 07316909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Binding protein as biosensors'
[patent_app_type] => utility
[patent_app_number] => 11/424892
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7182
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/316/07316909.pdf
[firstpage_image] =>[orig_patent_app_number] => 11424892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/424892 | Binding protein as biosensors | Jun 18, 2006 | Issued |
Array
(
[id] => 8675463
[patent_doc_number] => 08383576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized'
[patent_app_type] => utility
[patent_app_number] => 11/917848
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10640
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11917848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917848 | LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized | Jun 18, 2006 | Issued |
Array
(
[id] => 5279181
[patent_doc_number] => 20090131313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 11/917869
[patent_app_country] => US
[patent_app_date] => 2006-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10267
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131313.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917869
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917869 | LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TISSUE DETERIORATION, INJURY OR DAMAGE | Jun 18, 2006 | Abandoned |
Array
(
[id] => 5922561
[patent_doc_number] => 20060240525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Factor VII or VIIa - Like Molecules'
[patent_app_type] => utility
[patent_app_number] => 11/423665
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29157
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240525.pdf
[firstpage_image] =>[orig_patent_app_number] => 11423665
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/423665 | Factor VII or VIIa - like molecules | Jun 11, 2006 | Issued |